Blue water vaccines presents new data supporting universal influenza vaccine candidate at the world vaccine congress 2022 in washington, dc

Cincinnati, april 21, 2022 (globe newswire) -- blue water vaccines inc. (“bwv” or “blue water vaccines” or “the company”), a biopharmaceutical company developing transformational vaccines, today issued the below statement regarding its form 8-k filed with the securities and exchange commission (“sec”) on april 20, 2022, which included a presentation (the “wvc presentation”) delivered by the company at the world vaccine congress 2022 in washington, dc. this presentation by brian price, ph.d., bwv's head of technology strategy, shows identification of h3n2 and influenza b epitopes of limited variability discovered by scientists at the university of oxford.
BWV Ratings Summary
BWV Quant Ranking